Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Interim 6-month results of 2-year extension STEPS2 trial presented

Oct. 24, 2012

Genetic variations shared between obesity and ADHD identified

Oct. 24, 2012

Durable immune responses seen in vivo with HSV-2 vaccine

Oct. 24, 2012

Millennium presents first clinical results for two of its anticancer compounds

Oct. 24, 2012

JNJ-41477670: a novel TRPA1 antagonist with a promising pharmacokinetic profile

Oct. 24, 2012

Researchers from Canada link CX3CR1 to neural degeneration in CSM

Oct. 24, 2012

NXT-182 prevents neuronal apoptosis in vitro and increases neurogenesis in vivo

Oct. 23, 2012

Chugai presents interim phase II results for CH-5424802

Oct. 23, 2012

Tocilizumab shows positive effects in patients with neuromyelitis optica

Oct. 23, 2012

Gene polymorphism linked to acute lung injury in Gram-negative sepsis

Oct. 23, 2012

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...